What to make of the AstraZeneca vaccine data — and the surrounding controversy
(By Adam Feurerstein, Damian Garde, and Meg Tirrell for STAT) AstraZeneca’s up-and-down quest to develop a vaccine for Covid-19 stands
Read More(By Adam Feurerstein, Damian Garde, and Meg Tirrell for STAT) AstraZeneca’s up-and-down quest to develop a vaccine for Covid-19 stands
Read More(By Maia Anderson for Becker’s Hospital Review) Pharmaceutical companies have seen a sharp increase in positive public opinion over the
Read More(By Wyatt Koma, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation published March 23, 2021) More than 62 million
Read More(By Maia Anderson for Becker’s Hospital Review) The best-selling drug in the world in 2020 was AbbVie’s Humira, an immunology drug
Read More(By Alia Paavola for Becker’s Hospital Review) CMS has been quietly reviewing several of its payment models to decide if
Read More(By Andrew Joseph for STAT) U.S. health officials raised concerns early Tuesday that positive results that AstraZeneca announced Monday for
Read More(By Emmarie Huetteman for Kaiser Health News) Democrats, newly in control of Congress and the White House, are united behind an
Read More(By Bernard J. Wolfson for Kaiser Health News) As you surely know, this country’s covid vaccination effort has been plagued
Read More(By Maia Anderson for Becker’s Hospital Review) Eleven children’s hospitals and startup drugmaker Phlow have joined forces to create the Children’s
Read MoreThe U.S. District Court for the District of Columbia has issued a court order delaying the Department of Health and
Read More